Invesco Ltd. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$584,927
-20.9%
107,326
-2.6%
0.00%
Q2 2023$739,348
-21.3%
110,186
+3.5%
0.00%
Q1 2023$939,610
+30.7%
106,411
+13.1%
0.00%
Q4 2022$718,886
+10.1%
94,095
+2.6%
0.00%
Q3 2022$653,000
-14.5%
91,715
-2.9%
0.00%
Q2 2022$764,000
-62.3%
94,495
-35.2%
0.00%
-100.0%
Q1 2022$2,024,000
-95.3%
145,800
-90.6%
0.00%
-90.0%
Q4 2021$43,466,000
-15.5%
1,549,082
+2.4%
0.01%
-23.1%
Q3 2021$51,411,000
-17.9%
1,512,544
-1.3%
0.01%
-13.3%
Q2 2021$62,624,000
+17.9%
1,532,634
+16.2%
0.02%
+7.1%
Q1 2021$53,122,000
-41.1%
1,319,467
-13.4%
0.01%
-46.2%
Q4 2020$90,139,000
+46.0%
1,524,430
+20.1%
0.03%
+23.8%
Q3 2020$61,742,000
+3.7%
1,269,629
+3.2%
0.02%0.0%
Q2 2020$59,547,000
+853.5%
1,230,837
+447.5%
0.02%
+600.0%
Q1 2020$6,245,000
-18.3%
224,819
-12.0%
0.00%
+50.0%
Q4 2019$7,641,000
+7.6%
255,368
+11.1%
0.00%0.0%
Q3 2019$7,100,000
-34.7%
229,754
+2.1%
0.00%
-33.3%
Q2 2019$10,868,000225,0000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders